Latest AI and machine learning research in dementia for healthcare professionals.
Progesterone (PG) is used to slow the progression of neurodegenerative diseases, particularly Alzheimer's disease (AD) in postmenopausal women. However, PG exhibits high lipophilicity, resulting in strong binding to skin tissues and plasma proteins, which may limit its systemic transport via transdermal routes. Solid lipid nanoparticles (SLNs) have been highlighted for their potential to enhance d...
BACKGROUND: Digital health tools, particularly patient portals, can support caregiving, but there is limited understanding of how sociodemographic and geographic factors influence digital health engagement among U.S. caregivers, especially dementia caregivers. Dementia caregiving involves complex coordination, medication management, and frequent healthcare interactions. Therefore, access to online...
INTRODUCTION: Idiopathic normal pressure hydrocephalus (iNPH) is frequently underdiagnosed due to non-specific symptoms and the risks of invasive test...
BACKGROUND: Less women participate in Alzheimer Disease (AD) trials compared to their estimated representation in the global dementia population. OBJE...
While children with suicidal ideation or non-suicidal self-injury (NSSI) are at high risk of suicide, most do not attempt suicide. This study aims to ...
INTRODUCTION: Increased global lifespan is paralleled by a rise in non-communicable diseases with osteoarthritis and dementia, including Alzheimer's d...
BACKGROUND: Glymphatic system (GS) function and hippocampal microstructural changes are promising imaging markers of Alzheimer's disease (AD). This st...
BACKGROUND: Late-life depression (LLD) often co-occurs with mild cognitive impairment (MCI), and patients with LLD and MCI (LLD-MCI) have an increased...
OBJECTIVE: Mild cognitive impairment (MCI) is an intermediary stage between typical cognitive aging and dementia. Identifying reliable biomarkers for ...
INTRODUCTION: Thematic coding helps researchers characterize intervention implementation in embedded pragmatic clinical trials (ePCTs), particularly i...
AimTo evaluate and compare the performance of five artificial intelligence (AI) chatbots-ChatGPT (OpenAI 4), Google Gemini, Grok (xAI), DeepSeek, and ...
BACKGROUND AND OBJECTIVES: Respite care provides temporary relief to family caregivers yet remains underused, and the factors shaping its utilization ...
BackgroundPeople living with dementia (PLWD) with advanced illness are prone to respiratory distress yet often cannot self-report dyspnea, delaying re...
Accurate disease prognosis is essential for patient care but is often hindered by the scarcity of longitudinal data. This study explores deep learning...
People with semantic dementia (SD) or semantic variant primary progressive aphasia typically present with marked atrophy of the anterior temporal lobe...
BackgroundLucid episodes (LEs) in advanced dementia are significant clinical events yet are challenging to investigate as they are characterized by a ...
Alzheimer's disease (AD) is a complex, multifactorial neurodegenerative disorder with substantial heterogeneity in progression and treatment response....
We propose ADGNET, a semi-supervised framework for Alzheimer's disease (AD) diagnosis that jointly optimizes image reconstruction and classification t...
Variability in Alzheimer's disease (AD) clinical presentation complicates mechanistic studies and therapeutic outcome prediction. Brain protein aggreg...
BACKGROUND: Disability assessment in dementia is important for care planning, but the full World Health Organization Disability Assessment Schedule 2....